Discover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded by physician-scientists, the company has a unique ability to repeatedly and consistently translate science into medicine. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases.
4500 / day
5000 / day
3.2 pages per visit
Domain Rating
Domain Authority
Citation Level
English, etc
Pioneering research in genetics and molecular biology to develop novel therapies.
Comprehensive support programs for patients using Regeneron's medications.
Information on ongoing and upcoming clinical trials for new treatments.
Commitment to ethical practices, sustainability, and community support.
Explore career opportunities in a leading biotech company.
Detailed financial information, news, and events for investors.
Press releases, media contacts, and company news.
Resources for healthcare professionals and patients to learn about diseases and treatments.
Tarrytown, New York, United States
Leonard S. Schleifer (Founder, President, and CEO), George D. Yancopoulos (Founder, President, and Chief Scientific Officer)
Over 10,000
EYLEA, Dupixent, Libtayo, Praluent, Kevzara, among others
Numerous awards for innovation, workplace environment, and contributions to healthcare.
Initiatives to reduce environmental impact and promote sustainability in operations.
Programs and partnerships aimed at improving health and science education in communities.
Security headers report is a very important part of user data protection. Learn more about http headers for regeneron.com